Nutrition and mutagenesis

Annual Review of Nutrition

Volumn 28, Issue , 2008, Pages 313-329

  Ferguson, Lynnette R ^a   Philpott, Martin ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antimutagen; Atherosclerosis; Carcinogenesis; Genomic instability; Mutagen; Mutation

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; AFLATOXIN B1; ANTIMUTAGENIC AGENT; ASCORBIC ACID; BENZO[A]PYRENE; CAFFEINE; CAROTENOID; CHLOROPHYLL; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; FOLIC ACID; MUTAGENIC AGENT; OCHRATOXIN; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL DERIVATIVE; PTAQUILOSIDE; PYRROLIZIDINE ALKALOID; SELENIUM;

ATHEROSCLEROSIS; BASE PAIRING; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DIETARY FIBER; DNA REPAIR; FOOD INTAKE; GENE TECHNOLOGY; GENETIC POLYMORPHISM; GENETIC STABILITY; HUMAN; MITOSIS SPINDLE; MUTAGENESIS; NONHUMAN; NUTRIENT DYNAMICS; NUTRIENT SUPPLY; NUTRIGENOMICS; NUTRITION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW; STRUCTURAL CHROMOSOME ABERRATION;

ANIMALS; ANTIMUTAGENIC AGENTS; CARCINOGENS; DIET; DNA DAMAGE; GENOTYPE; HUMANS; MUTAGENESIS; MUTAGENS; NEOPLASMS; NUTRITION PHYSIOLOGY;

EID: 50949121897     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.28.061807.155449     Document Type: Review

References (81)

1. Am. Inst. Cancer Res., World Cancer Res. Fund (AICR-WCRF). 2007. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: Am. Inst. Cancer Res.
2. Ames BN. 1979. Identifying environmental chemicals causing mutations and cancer. Science 204:587-93
3. Ames BN. 2006. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. USA 103:17589-94
4. Ames BN, Durston WE, Yamasaki E, Lee FD. 1973. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA 70:2281-85
5. Andreassi MG, Botto N, Colombo MG, Biagini A, Clerico A. 2000. Genetic instability and atherosclerosis: Can somatic mutations account for the development of cardiovascular diseases? Environ. Mol. Mutagen. 35:265-69
6. Bacic A, Harris PJ, Stone BA. 1988. Structure and function of plant cell walls. In The Biochemistry of Plants, ed. J Preiss, pp. 297-371. New York: Academic
7. Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? Lancet 357:539-45
8. Bandele OJ, Osheroff N. 2007. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 46:6097-108
9. Barbin A. 2000. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res. 462:55-69
10. Bartsch H, Nair J. 2004. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation-driven carcinogenesis. Cancer Detect. Prev. 28:385-91
11. Benditt EP, Benditt JM. 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70:1753-56
12. Besaratinia A, Pfeifer GP. 2006. Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis 27:1526-37
13. Bingham SA, Pignatelli B, Pollock JR, Ellul A, Malaveille C, et al. 1996. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 17:515-23
14. Bodmer WF. 2006. Cancer genetics: colorectal cancer as a model. J. Hum. Genet. 51:391-96
15. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, et al. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625-31
16. Bridges BA, Bowyer DE, Hansen ES, Penn A, Wakabayashi K, eds. 1990. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques (special issue). Mutat. Res. 239:143-87
17. Busby WFJ, Wogan GN. 1984. Aflatoxins. In Chemical Carcinogens, ed. C Searle, pp. 945-1136. Washington, DC: Am. Chem. Soc.
18. Calin GA, Croce CM. 2007. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 117:2059-66
19. Collins AR. 2001. Carotenoids and genomic stability. Mutat. Res. 475:21-28
20. Collins AR. 2005. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am. J. Clin. Nutr. 81:261-67S
21. Commoner B, Vithayathil AJ, Dolara P, Nair S, Madyastha P, Cuca GC. 1978. Formation of mutagens in beef and beef extract during cooking. Science 201:913-16
22. Courtemanche C, Huang AC, Elson-Schwab I, Kerry N, Ng BY, Ames BN. 2004. Folate deficiency and ionizing radiation cause DNA breaks in primary human lymphocytes: a comparison. FASEB J. 18:209-11
23. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-67
24. Curfs DM, Knaapen AM, Pachen DM, Gijbels MJ, Lutgens E, et al. 2005. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA-binding properties. FASEB J. 19:1290-92
25. Davis CD, Ross SA. 2007. Dietary components impact histone modifications and cancer risk. Nutr. Rev. 65:88-94
26. Doll R, Peto R. 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1191-308
27. Essigmann JM, Green CL, Croy RG, Fowler KW, Buchi GH, Wogan GN. 1983. Interactions of aflatoxin B1 and alkylating agents with DNA: structural and functional studies. Cold Spring Harb. Symp. Quant. Biol. 47(Pt. 1):327-37
28. Evans IA, Mason J. 1965. Carcinogenic activity of bracken. Nature 208:913-14
29. Exon JH. 2006. A review of the toxicology of acrylamide. J. Toxicol. Environ. Health Pt. B Crit. Rev. 9:397-412
30. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-67
31. Fenech M, Ferguson LR. 2001. Vitamins/minerals and genomic stability in humans. Mutat. Res. 475:1-6
32. Ferguson LR. 1998. Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens. Mutat. Res. 400:271-78
33. Ferguson LR. 2006. Nutrigenomics: integrating genomic approaches into nutrition research. Mol. Diagn. Ther. 10:101-8
34. Ferguson LR, ed. 2007. Biomarkers as endpoints in intervention studies. In Molecular Epidemiology of Chronic Diseases: New Techniques and Approaches, ed. P Vineis, S Garte, C Wild, pp. 253-64. Indianapolis, IN: Wiley
35. Ferguson LR, Barnett MPG, McNabb WC. 2007. Genetic, epigenetics, nutrition and chronic disease. Agro-Food Ind. High Tech. 3:49-51
36. Ferguson LR, Gregory TJ, Pearson AE, Hay JE, Lewis GD. 1996. Mutagenicity tests as a monitoring tool for potential mutagens and carcinogens in shellfish gathering areas of New Zealand. N. Z. J. Marine Freshwater Res. 30:413-21
37. Ferguson LR, Philpott M. 2007. Cancer prevention by dietary bioactive components that target the immune response. Curr. Cancer Drug Targets 7:459-64
38. Ferguson LR, Philpott M, Karunasinghe N. 2004. Dietary cancer and prevention using antimutagens. Toxicology 198:147-59
39. Ferruzzi MG, Blakeslee J. 2007. Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives. Nutr. Res. 27:1-12
40. Fu PP, Xia Q, Lin G, Chou MW. 2004. Pyrrolizidine alkaloids - genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev. 36:1-55
41. Guarrera S, Sacerdote C, Fiorini L, Marsala R, Polidoro S, et al. 2007. Expression of DNA repair and metabolic genes in response to a flavonoid-rich diet. Br. J. Nutr. 98:525-33
42. Halliwell B. 2007. Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc. Res. 73:341-47
43. Halliwell B. 2007. Oxidative stress and cancer: Have we moved forward? Biochem. J. 401:1-11
44. Harris PJ, Ferguson LR. 1999. Dietary fibres may protect or enhance carcinogenesis. Mutat. Res. 443:95-110
45. Hu YJ, Diamond AM. 2003. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63:3347-51
46. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. 2007. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166-76
47. Izzotti A, De Flora S, Petrilli GL, Gallagher J, Rojas M, et al. 1995. Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol. Biomarkers Prev. 4:105-10
48. Karunasinghe N, Ryan J, Tuckey J, Masters J, Jamieson M, et al. 2004. DNA stability and strum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol. Biomarkers Prev. 13:391-97
49. Kim DH. 2007. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer. Mutat. Res. 622:14-18
50. Kim HS, Kwack SJ, Lee BM. 2000. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrenequinones in the blood of rats treated with benzo[a]pyrene. Chem. Biol. Interact. 127:139-50
51. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, et al. 2002. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113(Suppl. 9B):71-88S
52. Lampe JW. 2007. Diet, genetic polymorphisms, detoxification, and health risks. Altern. Ther. Health Med. 13:S108-11
53. Leblanc JC, Tard A, Volatier JL, Verger P. 2005. Estimated dietary exposure to principal food mycotoxins from the first French Total Diet Study. Food Addit. Contam. 22:652-72
54. Lijinsky W. 1999. N-nitroso compounds in the diet. Mutat. Res. 443:129-38
55. Mei N, Guo L, Fu PP, Heflich RH, Chen T. 2005. Mutagenicity of comfrey (Symphytum Officinale) in rat liver. Br. J. Cancer 92:873-75
56. Mirvish SS, Wallcave L, Eagen M, Shubik P. 1972. Ascorbate-nitrite reaction: possible meais of blocking the formation of carcinogenic N-nitroso compounds. Science 177:65-68
57. Nagao M, Honda M, Seino Y, Yahagi T, Sugimura T. 1977. Mutagenicities of smoke condensates and the charred surface of fish and meat. Cancer Lett. 2:221-26
58. Nair J, De Flora S, Izzotti A, Bartsch H. 2007. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat. Res. 621:95-105
59. Nakai Y, Nelson WG, De Marzo AM. 2007. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res. 67:1378-84
60. Ostertag W, Duisberg E, Sturmann M. 1965. The mutagenic activity of caffeine in man. Mutat. Res. 2:293-96
61. Pavanello S, Pulliero A, Saia BO, Clonfero E. 2006. Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population. Mutat. Res. 611:54-63
62. Penn A, Snyder C. 1988. Arteriosclerotic plaque development is "promoted" by polynuclear aromatic hydrocarbons. Carcinogenesis 9:2185-89
63. Pfohl-Leszkowicz A, Manderville RA. 2007. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51:61-99
64. Phillips DH. 1999. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 443:139-47
65. Pool-Zobel B, Veeriah S, Bohmer FD. 2005. Modulation of xenobiotic metabolising enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 591:74-92
66. Porta M, Vioque J, Ayude D, Alguacil J, Jariod M, et al. 2003. Coffee drinking: the rationale for treating it as a potential effect modifier of carcinogenic exposures. Eur. J. Epidemiol. 18:289-98
67. Prakash AS, Pereira TN, Reilly PE, Seawright AA. 1999. Pyrrolizidine alkaloids in human diet. Mutat. Res. 443:53-67
68. Ross JA, Potter JD, Robison LL. 1994. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J. Natl. Cancer Inst. 86:1678-80
69. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. 2001. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann. N. Y. Acad. Sci. 947:271-92; discussion 92-93
70. Shahin M, Smith BL, Prakash AS. 1999. Bracken carcinogens in the human diet. Mutat. Res. 443:69-79
71. Shelling AN, Ferguson LR. 2007. Genetic variation in human disease and a new role for copy number variants. Mutat. Res. 622:33-41
72. Smela ME, Currier SS, Bailey EA, Essigmann JM. 2001. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 22:535-45
73. Steiner C, Peters WH, Gallagher EP, Magee P, Rowland I, Pool-Zobel BL. 2007. Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system. Carcinogenesis 28:738-48
74. Sugimura T. 1982. Mutagens, carcinogens, and tumor promoters in our daily food. Cancer 49:1970-84
75. Turesky RJ. 2007. Formation and biochemistry of carcinogenic heterocyclic aromatic amines in cooked meats. Toxicol. Lett. 168:219-27
76. van Waalwijk van Doorn-Khosrovani SB, Janssen J, Maas LM, Godschalk RW, Nijhuis JG, van Schooten FJ. 2007. Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis 28:1703-9
77. Vineis P, Perera F. 2007. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol. Biomarkers Prev. 16:1954-65
78. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, et al. 2005. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26:1256-62
79. Wiseman H, Halliwell B. 1996. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:17-29
80. Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. 2004. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 25:1935-44
81. Yun CH, Jung U, Son CG, Ju HR, Han SH. 2006. 3-Amino-1,4-dimethyl-5H- pyrido[4,3-b]indole (Trp-P-1), a food-borne carcinogenic heterocyclic amine, promotes nitric oxide production in murine macrophages. Toxicol. Lett. 161:18-26